Thus, we subsequently tested the role of complement activation in cancer-induced muscle pathologies by injecting KPC pancreatic cancer cells into the pancreas of wild-type mice or mice null for the central component of complement 3 (C3). Here, C3 is linked to familial pancreatic carcinoma.